Medibank Private Stock Fundamentals
| MPL Stock | 3.83 0.02 0.52% |
Medibank Private fundamentals help investors to digest information that contributes to Medibank Private's financial success or failures. It also enables traders to predict the movement of Medibank Stock. The fundamental analysis module provides a way to measure Medibank Private's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medibank Private stock.
At this time, Medibank Private's Interest Expense is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 93.9 M in 2024, whereas Income Before Tax is likely to drop slightly above 405.2 M in 2024. Medibank | Select Account or Indicator |
Medibank Private Company Return On Asset Analysis
Medibank Private's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Medibank Private Return On Asset | 0.1 |
Most of Medibank Private's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medibank Private is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Medibank Total Assets
Total Assets |
|
Based on the latest financial disclosure, Medibank Private has a Return On Asset of 0.1038. This is 122.09% lower than that of the Insurance sector and significantly higher than that of the Financials industry. The return on asset for all Australia stocks is 174.14% lower than that of the firm.
Medibank Private Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medibank Private's current stock value. Our valuation model uses many indicators to compare Medibank Private value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medibank Private competition to find correlations between indicators driving Medibank Private's intrinsic value. More Info.Medibank Private is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medibank Private is roughly 2.10 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medibank Private's earnings, one of the primary drivers of an investment's value.Medibank Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medibank Private's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medibank Private could also be used in its relative valuation, which is a method of valuing Medibank Private by comparing valuation metrics of similar companies.Medibank Private is currently under evaluation in return on asset category among its peers.
Medibank Private ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medibank Private's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medibank Private's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Medibank Fundamentals
| Return On Equity | 0.22 | ||||
| Return On Asset | 0.1 | ||||
| Profit Margin | 0.0005 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 10.08 B | ||||
| Shares Outstanding | 2.75 B | ||||
| Shares Owned By Insiders | 0.12 % | ||||
| Shares Owned By Institutions | 42.17 % | ||||
| Price To Book | 4.57 X | ||||
| Price To Sales | 1.31 X | ||||
| Revenue | 8.02 B | ||||
| Gross Profit | 1.64 B | ||||
| EBITDA | 813.6 M | ||||
| Net Income | 3.9 M | ||||
| Cash And Equivalents | 420.6 M | ||||
| Total Debt | 218.3 M | ||||
| Book Value Per Share | 0.84 X | ||||
| Cash Flow From Operations | 868.5 M | ||||
| Earnings Per Share | 0.18 X | ||||
| Target Price | 4.08 | ||||
| Number Of Employees | 3.22 K | ||||
| Beta | 0.2 | ||||
| Market Capitalization | 10.55 B | ||||
| Total Asset | 4.69 B | ||||
| Retained Earnings | 2.07 B | ||||
| Annual Yield | 0.04 % | ||||
| Net Asset | 4.69 B | ||||
| Last Dividend Paid | 0.17 |
About Medibank Private Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medibank Private's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medibank Private using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medibank Private based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 48.7 M | 46.3 M | |
| Total Revenue | 8 B | 5.6 B | |
| Cost Of Revenue | 6.1 B | 5.6 B |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medibank Stock Analysis
When running Medibank Private's price analysis, check to measure Medibank Private's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibank Private is operating at the current time. Most of Medibank Private's value examination focuses on studying past and present price action to predict the probability of Medibank Private's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibank Private's price. Additionally, you may evaluate how the addition of Medibank Private to your portfolios can decrease your overall portfolio volatility.